Literature DB >> 32886252

Manifold learning for amyotrophic lateral sclerosis functional loss assessment : Development and validation of a prognosis model.

Vincent Grollemund1,2, Gaétan Le Chat3, Marie-Sonia Secchi-Buhour3, François Delbot4,5, Jean-François Pradat-Peyre4,5, Peter Bede6,7,8, Pierre-François Pradat6,7,9.   

Abstract

Amyotrophic lateral sclerosis (ALS) is an inexorably progressive neurodegenerative condition with no effective disease-modifying therapy at present. Given the striking clinical heterogeneity of the condition, the development and validation of reliable prognostic models is a recognised research priority. We present a prognostic model for functional decline in ALS where outcome uncertainty is taken into account. Patient data were reduced and projected onto a 2D space using Uniform Manifold Approximation and Projection (UMAP), a novel non-linear dimension reduction technique. Information from 3756 patients was included. Development data were sourced from past clinical trials. Real-world population data were used as validation data. Predictors included age, gender, region of onset, symptom duration, weight at baseline, functional impairment, and estimated rate of functional loss. UMAP projection of patients showed an informative 2D data distribution. As limited data availability precluded complex model designs, the projection was divided into three zones defined by a functional impairment range probability. Zone membership allowed individual patient prediction. Patients belonging to the first zone had a probability of [Formula: see text] (± [Formula: see text]) to have an ALSFRS score over 20 at 1-year follow-up. Patients within the second zone had a probability of [Formula: see text] (± [Formula: see text]) to have an ALSFRS score between 10 and 30 at 1 year follow-up. Finally, patients within the third zone had a probability of [Formula: see text] (± [Formula: see text]) to have an ALSFRS score lower than 20 at 1 year follow-up. This approach requires a limited set of features, is easily updated, improves with additional patient data, and accounts for results uncertainty. This method could therefore be used in a clinical setting for patient stratification and outcome projection.

Entities:  

Keywords:  ALS; Manifold learning; Non-linear dimension reduction; Prognosis; UMAP

Mesh:

Year:  2020        PMID: 32886252     DOI: 10.1007/s00415-020-10181-2

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  15 in total

1.  The effects of executive and behavioral dysfunction on the course of ALS.

Authors:  R K Olney; J Murphy; D Forshew; E Garwood; B L Miller; S Langmore; M A Kohn; C Lomen-Hoerth
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

Review 2.  The phenotypic variability of amyotrophic lateral sclerosis.

Authors:  Bart Swinnen; Wim Robberecht
Journal:  Nat Rev Neurol       Date:  2014-10-14       Impact factor: 42.937

3.  The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III).

Authors:  J M Cedarbaum; N Stambler; E Malta; C Fuller; D Hilt; B Thurmond; A Nakanishi
Journal:  J Neurol Sci       Date:  1999-10-31       Impact factor: 3.181

4.  Spinal cord multi-parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis.

Authors:  G Querin; M M El Mendili; T Lenglet; S Delphine; V Marchand-Pauvert; H Benali; P-F Pradat
Journal:  Eur J Neurol       Date:  2017-06-06       Impact factor: 6.089

5.  Performance of the Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS) in multicenter clinical trials.

Authors:  J M Cedarbaum; N Stambler
Journal:  J Neurol Sci       Date:  1997-10       Impact factor: 3.181

6.  Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.

Authors:  M Elamin; J Phukan; P Bede; N Jordan; S Byrne; N Pender; O Hardiman
Journal:  Neurology       Date:  2011-04-05       Impact factor: 9.910

7.  Cognitive changes predict functional decline in ALS: a population-based longitudinal study.

Authors:  Marwa Elamin; Peter Bede; Susan Byrne; Norah Jordan; Laura Gallagher; Brona Wynne; Caoimhe O'Brien; Julie Phukan; Catherine Lynch; Niall Pender; Orla Hardiman
Journal:  Neurology       Date:  2013-04-03       Impact factor: 9.910

Review 8.  The changing scene of amyotrophic lateral sclerosis.

Authors:  Wim Robberecht; Thomas Philips
Journal:  Nat Rev Neurosci       Date:  2013-03-06       Impact factor: 34.870

9.  Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm.

Authors:  Marwa Elamin; Peter Bede; Anna Montuschi; Niall Pender; Adriano Chio; Orla Hardiman
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

10.  Functional Ultrasound (fUS) During Awake Brain Surgery: The Clinical Potential of Intra-Operative Functional and Vascular Brain Mapping.

Authors:  Sadaf Soloukey; Arnaud J P E Vincent; Djaina D Satoer; Frits Mastik; Marion Smits; Clemens M F Dirven; Christos Strydis; Johannes G Bosch; Antonius F W van der Steen; Chris I De Zeeuw; Sebastiaan K E Koekkoek; Pieter Kruizinga
Journal:  Front Neurosci       Date:  2020-01-09       Impact factor: 4.677

View more
  8 in total

1.  Prognostic models for amyotrophic lateral sclerosis: a systematic review.

Authors:  Lu Xu; Bingjie He; Yunjing Zhang; Lu Chen; Dongsheng Fan; Siyan Zhan; Shengfeng Wang
Journal:  J Neurol       Date:  2021-03-10       Impact factor: 4.849

2.  Pathological neural networks and artificial neural networks in ALS: diagnostic classification based on pathognomonic neuroimaging features.

Authors:  Peter Bede; Aizuri Murad; Orla Hardiman
Journal:  J Neurol       Date:  2021-09-28       Impact factor: 6.682

3.  White matter microstructure alterations in frontotemporal dementia: Phenotype-associated signatures and single-subject interpretation.

Authors:  Mary Clare McKenna; Marlene Tahedl; Aizuri Murad; Jasmin Lope; Orla Hardiman; Siobhan Hutchinson; Peter Bede
Journal:  Brain Behav       Date:  2022-01-24       Impact factor: 2.708

4.  Mapping cortical disease-burden at individual-level in frontotemporal dementia: implications for clinical care and pharmacological trials.

Authors:  Mary Clare McKenna; Marlene Tahedl; Jasmin Lope; Rangariroyashe H Chipika; Stacey Li Hi Shing; Mark A Doherty; Jennifer C Hengeveld; Alice Vajda; Russell L McLaughlin; Orla Hardiman; Siobhan Hutchinson; Peter Bede
Journal:  Brain Imaging Behav       Date:  2021-12-09       Impact factor: 3.224

5.  Deep learning methods to predict amyotrophic lateral sclerosis disease progression.

Authors:  Corrado Pancotti; Giovanni Birolo; Cesare Rollo; Tiziana Sanavia; Barbara Di Camillo; Umberto Manera; Adriano Chiò; Piero Fariselli
Journal:  Sci Rep       Date:  2022-08-12       Impact factor: 4.996

6.  Predicting functional impairment trajectories in amyotrophic lateral sclerosis: a probabilistic, multifactorial model of disease progression.

Authors:  Erica Tavazzi; Sebastian Daberdaku; Alessandro Zandonà; Rosario Vasta; Vivian Drory; Marc Gotkine; Adriano Chiò; Barbara Di Camillo; Beatrice Nefussy; Christian Lunetta; Gabriele Mora; Jessica Mandrioli; Enrico Grisan; Claudia Tarlarini; Andrea Calvo; Cristina Moglia
Journal:  J Neurol       Date:  2022-03-10       Impact factor: 6.682

7.  Machine-learning in motor neuron diseases: Prospects and pitfalls.

Authors:  Peter Bede; Kai Ming Chang; Ee Ling Tan
Journal:  Eur J Neurol       Date:  2022-06-21       Impact factor: 6.288

8.  Clusters of anatomical disease-burden patterns in ALS: a data-driven approach confirms radiological subtypes.

Authors:  Peter Bede; Aizuri Murad; Jasmin Lope; Orla Hardiman; Kai Ming Chang
Journal:  J Neurol       Date:  2022-03-25       Impact factor: 6.682

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.